Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
- AbbVie
- Actelion
- Algeta
- Alpharadin
- Anacetrapib
- Bardoxolone
- Bayer
- BG-12
- Biogen Idec
- Bristol-Myers Squibb
- darapladib
- Eliquis
- gantenerumab
- Gilead
- GS-7977
- GSK
- Immunogen
- Lundbeck
- macitentan
- Merck
- MorphoSys
- Novartis
- Odanacatib
- Pfizer
- QVA149
- Reata
- Regeneron
- REGN727
- Roche
- Sanofi
- T-DM1
- Takeda
- tofacitinib
- Vectura
- vortioxetine